erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Ruess M et al. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. 2000 Scand. J. Infect. Dis. pmid:11200371
Shulman ST and Ayoub EM The control of rheumatic fever. 1975 Clin Pediatr (Phila) pmid:1120375
Mazur E et al. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections. 1999 Ann Univ Mariae Curie Sklodowska Med pmid:11205800
Mikucka A et al. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998. 2000 Mar-Apr Med. Sci. Monit. pmid:11208326
Izard J et al. Cytoplasmic filament-deficient mutant of Treponema denticola has pleiotropic defects. 2001 J. Bacteriol. pmid:11208807
Bombassaro AM et al. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. 2001 J Can Dent Assoc pmid:11209501
Arciola CR et al. Adhesion to a polymeric biomaterial affects the antibiotic resistance of Staphylococcus epidermidis. 2001 New Microbiol. pmid:11209844
Sáez-Llorens X et al. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia]. 1998 Rev Med Panama pmid:11214557
Gilliet F [Treatment of early syphilis under conditions of penicillin intolerance]. 1975 Schweiz Med Wochenschr pmid:1121651
Warkany J A warfarin embryopathy? 1975 Am. J. Dis. Child. pmid:1121959
de Dios García-Díaz J et al. [Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin]. 2001 Med Clin (Barc) pmid:11222159
van der Toorn F and Lumeij JT [Streptococcus gallolyticus infections in racing pigeons, a literature review]. 2001 Tijdschr Diergeneeskd pmid:11227399
Alimchandani A and Pai-dhungat JV A study of gastric emptying in chronic renal failure. 1997 J Assoc Physicians India pmid:11229179
Pfeifer BA et al. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. 2001 Science pmid:11230695
Labro MT and Abdelghaffar H Immunomodulation by macrolide antibiotics. 2001 J Chemother pmid:11233797
Hashimoto N et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. 2001 J. Lab. Clin. Med. pmid:11241027
Hofstetter A [Treatment of chlamydial urethroadnexitis with erythromycin (author's transl)]. 1979 MMW Munch Med Wochenschr pmid:112423
Nasser AA and Bizri AR Chronic scalp wound infection due to Rhodococcus equi in an immunocompetent patient. 2001 J. Infect. pmid:11243757
Uh Y et al. Emerging erythromycin resistance among group B streptococci in Korea. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11245325
Stamos G et al. Emergence of group A beta-hemolytic streptococci resistant to erythromycin in Athens, Greece. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11245331
Hladka OA and Motyka OI [Formation of erythromycin resistance in Corynebacterium diphtheriae induced by long-term effect of the antibiotic]. 2000 Sep-Oct Mikrobiol. Z. pmid:11247343
Wagner CM The care and management of pertussis in pediatric patients. 2001 Mar-Apr Air Med. J. pmid:11250611
Ross JI et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. 2001 Br. J. Dermatol. pmid:11251569
Bergogne-Bérézin E and Bryskier A The suppository form of antibiotic administration: pharmacokinetics and clinical application. 1999 J. Antimicrob. Chemother. pmid:11252322
Fernández-Roblas R et al. The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance. 1999 J. Antimicrob. Chemother. pmid:11252337
Nait-Kaci S et al. [Sensitivity to beta lactams and macrolides of Streptococcus pyogenes isolated at the services from 1994 to 1998]. 1998 Arch Inst Pasteur Alger pmid:11256303
Perreten V et al. Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. 2001 Antimicrob. Agents Chemother. pmid:11257023
Koeck JL et al. [First confirmed case of laryngeal diphtheria in Djibouti]. 2000 Med Trop (Mars) pmid:11258062
Yamano K et al. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data. 2001 Drug Metab. Dispos. pmid:11259329
Oliva Rodríguez-Pastor S et al. [Erythromycin and hypertrophic stenosis of the pylorus]. 2001 An. Esp. Pediatr. pmid:11262265
Lunzer MR et al. Jaundice due to erythromycin estolate. 1975 Gastroenterology pmid:1126604
Sanz E et al. Perception of teratogenic risk of common medicines. 2001 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:11267734
Schwartz JB Race but not age affects erythromycin breath test results in older hypertensive men. 2001 J Clin Pharmacol pmid:11269573
Cervin A The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. 2001 Acta Otolaryngol. pmid:11270500
Champney WS and Tober CL Structure-activity relationships for six ketolide antibiotics. 2001 Curr. Microbiol. pmid:11270656
Ye H et al. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro. 1999 Zhongguo Yao Li Xue Bao pmid:11270970
Avanzini C et al. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD. 2000 Microb. Drug Resist. pmid:11272257
Steigbigel RT et al. Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection. 1975 J. Infect. Dis. pmid:1127254
Papudesu B et al. Invasive pneumococcal disease. 2001 Med Health R I pmid:11280137
Leyden JJ et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. 2001 Jan-Feb J Cutan Med Surg pmid:11281433
Ioannidou S et al. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. 2001 Int. J. Antimicrob. Agents pmid:11282264
Zouain MG and Araj GF Antimicrobial resistance of Enterococci in Lebanon. 2001 Int. J. Antimicrob. Agents pmid:11282266
Vela AI et al. Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep. 2001 Int. J. Antimicrob. Agents pmid:11282267
Montanari MP et al. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. 2001 J. Clin. Microbiol. pmid:11283047
Osato MS et al. Comparative efficacy of new investigational agents against Helicobacter pylori. 2001 Aliment. Pharmacol. Ther. pmid:11284777
Kanellopoulou M et al. Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens. 2000 Clin. Microbiol. Infect. pmid:11284924
Bryskier A Ketolides-telithromycin, an example of a new class of antibacterial agents. 2000 Clin. Microbiol. Infect. pmid:11284926
Ge N et al. Interferon-gamma activates outwardly rectifying chloride channels in the human bronchial epithelial cell line BEAS-2B. 2001 J. Med. Invest. pmid:11286023
Ueno N et al. Erythromycin administration before sleep is effective in decreasing fasting hyperglycemia in type 2 diabetic patients. 2001 Diabetes Care pmid:11289494
Queille-Roussel C et al. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. 2001 Clin Ther pmid:11293554